Aarkstore - Healthcare Market Access Egypt

1
Healthcare Market Access Egypt
Technically speaking, Egypt offers a universal
health care system. Still, quality of care in
public hospitals is far lower than in private and
foreign clinics. The main government bodies
governing Egypt's health care system are the
Ministry of Health (MoH) and the Health Insurance
Organization (HIO).
2
Summary

• The report provides in-depth information ono
  Country Landscape This section covers
  information on the prevailing economic
  environment in the country and the reform efforts
  being taken. The GDP growth has improved
  indicating trends in the economic indicators and
  improvement. The demographic profile of the
  country indicates that a majority of the
  population is youngo Healthcare infrastructure
  Insightful review of the countrys healthcare
  system and health status with key health
  indicators are presented in this section.
  Moreover, healthcare expenditure and major
  healthcare providers are mentioned. The profiles
  of major hospitals and the number of healthcare
  personnel in the country are also covered.o
  Overview of Pharmaceutical Market This section
  depicts the pharmaceutical market in terms of
  size, growth, product mix and key players
  operating in the country. A special emphasis has
  been laid on the key drivers and barriers
  impacting the pharmaceutical market of the
  country. Furthermore, major diseases with high
  burden for the country have been covered.
• o Market Access This section dwells on the role
  and importance of various stakeholders in product
  commercialization process and gatekeepers holding
  the key to the access for pharmaceutical
  products. Various regulatory aspects crucial for
  approval and marketing of various categories of
  pharmaceutical products have been captured. In
  addition, analysis of pricing and reimbursement
  landscape along with the prescribing policies are
  covered.

3
Why should you buy this report

• As every countrys market access landscape is
  unique and evolving, it makes a prudent decision
  to have a country specific market access
  strategy. Moreover, the success of any
  pharmaceutical company hinges on successfully
  navigating challenges posed by the various
  stakeholders and regulatory bodies for effective
  product commercialization. This report will
  serve as a handy tool for pharmaceutical and
  other related healthcare stakeholders to
  Understand the macro and micro parameters that
  will play a pivotal role in making business
  decisions Identify, target and collaborate with
  the relevant stakeholders that hold key to
  effective product commercialization
  Conceptualize and formulate plausible market
  access strategies based on the insights generated
  Identify and foresee the major trends and
  policies likely to impact the regulatory, pricing
  and reimbursement landscape of the country
• Capitalize on the opportunities presented by
  the countrys pharmaceutical market and mitigate
  the challenges posed by the competitors and
  stakeholders/regulatory bodies Generate market
  specific insights that are actionable and
  commercially viable Leverage market access
  insights by incorporating physicians and payer
  priorities so as to develop effective sales and
  marketing strategies resulting in increased brand
  and company revenue Correctly ascertain the
  appropriate market access levers and barriers
  that will drive or hamper the brand performance
  Prioritize and assign optimal resources required
  for implementation of various market access
  activities

4
Table of Content

• EXECUTIVE SUMMARY
• COUNTRY LANDSCAPE
• OVERVIEW OF THE PHARMACEUTICAL MARKET
• HEALTHCARE INFRASTRUCTURE
• MARKET ACCESS
• CONCLUSION
• APPENDIX

5
List of Tables

• Table 1 Egypt - Selected economic indicators
  projections, 2010/11 - 2014/15 (Percent of GDP,
  unless otherwise indicated) 9
• Table 2 Other manufacturers include 13
• Table 3 Healthcare providers in Egypt 16
• Table 4 Spending on Health in Egypt 26
• Table 5 Median Price Ratios (MPR) in MOHP
  central tender and university hospitals 40
• Table 6 Median Price Ratios (MPR) in private
  pharmacies 41
• Table 7 Price affordability of some drugs in
  Egypt 41
• Table 8 Egyptian Essential Drug List 2012-2013
  46
• Table 9 Medicines with age or weight
  restrictions 74
• Table 10 Egyptian Essential Drug (Terms and
  Definitions) 75

6
List of Figures

• Figure 1 Financing agents as a percentage of
  total health expenditure (THE) 18Figure 2
  Funding utilization 18Figure 3 Trends in early
  childhood mortality in Egypt 20Figure 4 Risk
  factors in adults in Egypt 22Figure 5 Sources
  of financing healthcare as a percentage of THE
  27Figure 6 Outpatient visits per capita per
  year 31Figure 7 Inpatient bed-days per capita
  per year 32Figure 8 Inequities in women care
  32Figure 9 Inequities in child care 33Figure
  10 Reimbursement decision process 38

Browse full report Or Sample Request
_at_ http//www.aarkstore.com/pharmaceuticals-healthc
are/117428/healthcare-market-access-egypt
7
Related Reports

• Global Raman Spectroscopy Industry 2015 Market
  Research Report
• Global Contraceptives Industry Report 2015
• Prescription Drugs Industry Forecasts - China
  Focus
• Cardiovascular Devices Industry Forecasts - China
  Focus
• Emerging Pharmaceuticals Industry Forecasts -
  China Focus

8
Follow Us
https//www.facebook.com/aarkstoredotcom
https//twitter.com/aarkstore
https//plus.google.com/Aarkstoredotcom/posts
https//www.linkedin.com/company/aarkstore-enterpr
ise
9
Contact Us
Office Address Office No. - 809, 8th
Floor,B-Wing, Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Mail us at
contact_at_aarkstore.com 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756
4953